miR-590-5p Overexpression Alleviates β-Amyloid-Induced Neuron Damage via Targeting Pellino-1
Open Access
- 8 March 2022
- journal article
- research article
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2022, 1-13
Abstract
Alzheimers disease (AD) is one common degenerative disorder. However, the effects of miR-590-5p on AD and the mechanism on modulation of AD development were unclear. In this study, the miR-590-5p level in AD patients at mild, moderate, and severe stage as well as APP/PS1 transgenic mice was detected by qRT-PCR. The relationship of miR-590-5p and pellino-1 (PELI1) was identified by double luciferase reporter gene assay. Afterwards, both BV-2 and HT22 cells were exposed to β-amyloid (Aβ) peptides to mimic AD cell model. Then, the roles of miR-590-5p upregulation or PELI1 silence in cell proliferation and apoptosis were explored by CCK-8 assay and TUNEL assay, and the expression of apoptosis-related proteins was detected by western blotting. Furthermore, the involvements of the downstream Traf3/MAPK P38 pathway with the roles of miR-590-5p in AD were measured by western blotting. Our results showed that knockdown of miR-590-5p was found in AD patients, mice model, and Aβ-induced cell model. Notably, PELI1 was proved as a target gene of miR-590-5p. miR-590-5p mimic or PELI1 silence significantly promoted cell proliferation and inhibited cell apoptosis, as well as suppressed the activation of Traf3/MAPK P38 pathway both in Aβ-induced BV-2 and HT22 cells. The effects of PELI1 overexpression on cell proliferation, apoptosis, and Traf3/MAPK P38 pathway were partly abrogated by miR-590-5p mimic both in BV-2 and HT22 cells. In conclusion, miR-590-5p was expressed at lower levels in AD, and miR-590-5p/PELI1 axis might be involved in the progression of AD by the downstream Traf3/MAPK P38 pathway.Keywords
Funding Information
- National Natural Science Foundation of China (U1704166, 212102310217)
- Scientific and Technological Research Project of Henan Provincial Department of Science and Technology (U1704166, 212102310217)
This publication has 31 references indexed in Scilit:
- Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer’s diseaseNeuropharmacology, 2016
- Recombinant pre-miR-29b for Alzheimer´s disease therapeuticsScientific Reports, 2016
- Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseasesGenes, Chromosomes and Cancer, 2015
- miRNAs and viroids utilize common strategies in genetic signal transferFrontiers in Molecular Neuroscience, 2014
- Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradationNature Medicine, 2013
- MiR-590-5P Inhibits Growth of HepG2 Cells via Decrease of S100A10 Expression and Inhibition of the Wnt PathwayInternational Journal of Molecular Sciences, 2013
- FBXO15 regulates P‐glycoprotein/ABCB1 expression through the ubiquitin–proteasome pathway in cancer cellsCancer Science, 2013
- Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino 1 in the innate immune systemBiochemical Journal, 2011
- P38 MAP kinase is activated at early stages in Alzheimer's disease brainExperimental Neurology, 2003
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991